Hail First Pharma Inc.
Hail First Pharma Trading to Resume at the Open on June 22, 2011
Hail First Pharma Inc. / Key word(s): Miscellaneous 22.06.2011 / 13:00 Hail First Pharma Trading to Resume at the Open on June 22, 2011 Dubai - UAE - June 21, 2011 - Hail First Pharma Inc. formerly Zoloto Ventures Corp. (Frankfurt: 499A) Announced today that the Deutsche Börse will resume trading of its shares on June 22, 2011. The company's corporate action became effective on June 17, 2011 and the ticker symbol and CUSIP has changed to 499A and CA40522C1086. About Hail First Pharma Hail First Pharma is a pharmaceutical company specializing in acquiring, licensing and distributing of diabetic drugs, drug delivery technology, nutritional products and medical equipment. Important Information About Forward-Looking Statements in this press release may be 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as 'anticipate,' 'believe,' 'estimate,' 'expect,' 'intend' and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above. In addition, such statements could be affected by risks and uncertainties related to the exploration for and development of mineralized material, product demand, market and customer acceptance, competition, pricing and development difficulties, as well as general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Company's website does not constitute a part of this release.Contact: Hail First Pharma Inc. DRG Advisors LLC Hussain Al-Awaid Robert Albi Chairman President hailfirstpharma@gmail.com Tel. 516-351-8562End of Corporate News --------------------------------------------------------------------- 22.06.2011 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- 129430 22.06.2011
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden